mitomycin has been researched along with norfloxacin in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Badrinarayanan, A; Daw, S; Hasan, MM; Joseph, AM; Le, TBK; Lo, R; Nahar, K; Rahman, KM | 1 |
| Fay, M; Gougerot-Pocidalo, MA; Roche, Y | 1 |
| Fujii, J; Taniguchi, H; Yoshida, S; Yoshimura, K | 1 |
| Loś, JM; Loś, M; Wegrzyn, A; Wegrzyn, G | 1 |
| Darby, AC; Edwards, C; Hall, N; Horsburgh, MJ; Kenny, JG; Shankar, J; Yasmin, A | 1 |
| Clokie, MR; Fawley, WN; Hickenbotham, PT; Nale, JY; Shan, J; Wilcox, MH | 1 |
1 review(s) available for mitomycin and norfloxacin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for mitomycin and norfloxacin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Mechanistic insight into the repair of C8-linked pyrrolobenzodiazepine monomer-mediated DNA damage.
Topics: | 2022 |
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Mitomycin; Mitomycins; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Receptors, Immunologic; Receptors, Interleukin-2 | 1988 |
Chemotherapy for enterohemorrhagic Escherichia coli O157:H infection in a mouse model.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Toxins; Colony Count, Microbial; Drug Synergism; Enterotoxins; Escherichia coli Infections; Escherichia coli O157; Feces; Fosfomycin; Injections, Intraperitoneal; Kanamycin; Male; Mice; Mice, Inbred ICR; Minocycline; Mitomycin; Norfloxacin; Shiga Toxin 2 | 1999 |
Differential efficiency of induction of various lambdoid prophages responsible for production of Shiga toxins in response to different induction agents.
Topics: Amino Acid Sequence; Bacteriophage lambda; Base Sequence; Gene Expression Regulation, Viral; Genes, Reporter; Hydrogen Peroxide; Mitomycin; Molecular Sequence Data; Norfloxacin; Nucleic Acid Synthesis Inhibitors; Oxidants; Promoter Regions, Genetic; Prophages; Regulatory Sequences, Nucleic Acid; Shiga Toxin; Shiga-Toxigenic Escherichia coli; Sodium Chloride; Time Factors; Viral Proteins; Virus Activation | 2009 |
Comparative genomics and transduction potential of Enterococcus faecalis temperate bacteriophages.
Topics: Anti-Bacterial Agents; Bacteremia; Bacteriophages; DNA Fingerprinting; DNA, Viral; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecalis; Gene Order; Genome, Viral; Gram-Positive Bacterial Infections; Humans; Microscopy, Electron, Transmission; Mitomycin; Molecular Sequence Data; Norfloxacin; Prophages; Sequence Analysis, DNA; Sequence Homology; Synteny; Transduction, Genetic; Ultraviolet Rays; Virion; Virus Activation | 2010 |
Diverse temperate bacteriophage carriage in Clostridium difficile 027 strains.
Topics: Base Sequence; Capsid Proteins; Caudovirales; Cloning, Molecular; Clostridioides difficile; Cluster Analysis; Computational Biology; DNA Primers; Electrophoresis, Gel, Pulsed-Field; Microscopy, Electron, Transmission; Mitomycin; Molecular Sequence Data; Norfloxacin; Phylogeny; Prophages; Ribotyping; Sequence Analysis, DNA; Species Specificity; Virus Activation | 2012 |